{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:52Z","timestamp":1790168452706,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1286\/21"],"award-info":[{"award-number":["1286\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance is a major healthcare burden, aggravated when it extends to multiple drugs. While cross-resistance is well-studied experimentally, it is not the case in clinical settings, and especially not while considering confounding. Here, we estimated patterns of cross-resistance from clinical samples, while controlling for multiple clinical confounders and stratifying by sample sources.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employed additive Bayesian network (ABN) modelling to examine antibiotic cross- resistance in five major bacterial species, obtained from different sources (urine, wound, blood, and sputum) in a clinical setting, collected in a large hospital in Israel over a 4-year period. Overall, the number of samples available were 3525 for <jats:italic>E coli<\/jats:italic>, 1125 for <jats:italic>K pneumoniae<\/jats:italic>, 1828 for <jats:italic>P aeruginosa<\/jats:italic>, 701 for <jats:italic>P mirabilis<\/jats:italic>, and 835 for <jats:italic>S aureus<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patterns of cross-resistance differ across sample sources. All identified links between resistance to different antibiotics are positive. However, in 15 of 18 instances, the magnitudes of the links are significantly different between sources. For example, <jats:italic>E coli<\/jats:italic> exhibits adjusted odds ratios of gentamicin-ofloxacin cross-resistance ranging from 3.0 (95%CI [2.3,4.0]) in urine samples to 11.0 (95%CI [5.2,26.1]) in blood samples. Furthermore, we found that for <jats:italic>P mirabilis<\/jats:italic>, the magnitude of cross-resistance among linked antibiotics is higher in urine than in wound samples, whereas the opposite is true for <jats:italic>K pneumoniae<\/jats:italic> and <jats:italic>P aeruginosa<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results highlight the importance of considering sample sources when assessing likelihood of antibiotic cross-resistance. The information and methods described in our study can refine future estimation of cross-resistance patterns and facilitate determination of antibiotic treatment regimens.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-023-00289-7","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:07:50Z","timestamp":1683050870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bayesian network modeling of patterns of antibiotic cross-resistance by bacterial sample source"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0269-3352","authenticated-orcid":false,"given":"Stacey S.","family":"Cherny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Chowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-9745","authenticated-orcid":false,"given":"Uri","family":"Obolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","volume":"22","author":"ND Friedman","year":"2016","unstructured":"Friedman, N. D., Temkin, E. & Carmeli, Y. The negative impact of antibiotic resistance. Clin. Microbiol. Infect. 22, 416\u2013422 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"289_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1126\/science.aax3879","volume":"365","author":"RC MacLean","year":"2019","unstructured":"MacLean, R. C. & San Millan, A. The evolution of antibiotic resistance. Science 365, 1082\u20131083 (2019).","journal-title":"Science"},{"key":"289_CR3","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1093\/cid\/ciaa1576","volume":"72","author":"O Lewin-Epstein","year":"2021","unstructured":"Lewin-Epstein, O., Baruch, S., Hadany, L., Stein, G. Y. & Obolski, U. Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records. Clin. Infect. Dis. 72, e848\u2013e855 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"289_CR4","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1473-3099(18)30296-2","volume":"18","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee, A. et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect. Dis. 18, e368\u2013e378 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","volume":"5","author":"L Imamovic","year":"2013","unstructured":"Imamovic, L. & Sommer, M. O. A. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5, 204ra132\u2013204ra132 (2013).","journal-title":"Sci. Transl. Med."},{"key":"289_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tim.2015.02.009","volume":"23","author":"C P\u00e1l","year":"2015","unstructured":"P\u00e1l, C., Papp, B. & L\u00e1z\u00e1r, V. Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol. 23, 401\u2013407 (2015).","journal-title":"Trends Microbiol."},{"key":"289_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5352","volume":"5","author":"V L\u00e1z\u00e1r","year":"2014","unstructured":"L\u00e1z\u00e1r, V. et al. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 5, 4352 (2014).","journal-title":"Nat. Commun."},{"key":"289_CR8","doi-asserted-by":"publisher","first-page":"262ra156","DOI":"10.1126\/scitranslmed.3009940","volume":"6","author":"C Munck","year":"2014","unstructured":"Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H. & Sommer, M. O. A. Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci. Transl. Med. 6, 262ra156\u2013262ra156 (2014).","journal-title":"Sci. Transl. Med."},{"key":"289_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/eva.12903","volume":"13","author":"NA Lozano-Huntelman","year":"2020","unstructured":"Lozano-Huntelman, N. A. et al. Evolution of antibiotic cross-resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window. Evol. Appl. 13, 808\u2013823 (2020).","journal-title":"Evol. Appl."},{"key":"289_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/eva.12762","volume":"12","author":"A Colclough","year":"2019","unstructured":"Colclough, A., Corander, J., Sheppard, S. K., Bayliss, S. C. & Vos, M. Patterns of cross-resistance and collateral sensitivity between clinical antibiotics and natural antimicrobials. Evol. Appl. 12, 878\u2013887 (2019).","journal-title":"Evol. Appl."},{"key":"289_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1128\/AAC.26.6.797","volume":"26","author":"CC Sanders","year":"1984","unstructured":"Sanders, C. C., Sanders, W. E., Goering, R. V. & Werner, V. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob. Agents Chemother. 26, 797\u2013801 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"289_CR12","doi-asserted-by":"publisher","first-page":"757833","DOI":"10.3389\/fmicb.2021.757833","volume":"12","author":"F Baquero","year":"2021","unstructured":"Baquero, F. et al. Allogenous selection of mutational collateral resistance: old drugs select for new resistance within antibiotic families. Front. Microbiol. 12, 757833 (2021).","journal-title":"Front. Microbiol."},{"key":"289_CR13","doi-asserted-by":"crossref","unstructured":"Beckley, A. M. & Wright, E. S. Identification of antibiotic pairs that evade concurrent resistance via a retrospective analysis of antimicrobial susceptibility test results. Lancet Microbe 2, e545-e554 (2021).","DOI":"10.1016\/S2666-5247(21)00118-X"},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"dlab175","DOI":"10.1093\/jacamr\/dlab175","volume":"3","author":"LB Zwep","year":"2021","unstructured":"Zwep, L. B. et al. Identification of antibiotic collateral sensitivity and resistance interactions in population surveillance data. JAC-Antimicrob. Resist. 3, dlab175 (2021).","journal-title":"JAC-Antimicrob. Resist."},{"key":"289_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/jac\/dkaa408","volume":"76","author":"SS Cherny","year":"2021","unstructured":"Cherny, S. S. et al. Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling. J. Antimicrob. Chemother. 76, 239\u2013248 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"289_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.meegid.2016.02.017","volume":"40","author":"U Obolski","year":"2016","unstructured":"Obolski, U., Dellus-Gur, E., Stein, G. Y. & Hadany, L. Antibiotic cross-resistance in the lab and resistance co-occurrence in the clinic: discrepancies and implications in E.coli. Infect. Genet. Evol. 40, 155\u2013161 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"289_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.burns.2005.10.017","volume":"32","author":"A Japoni","year":"2006","unstructured":"Japoni, A. et al. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. Burns 32, 343\u2013347 (2006).","journal-title":"Burns"},{"key":"289_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12917-019-1965-y","volume":"15","author":"S Hartnack","year":"2019","unstructured":"Hartnack, S. et al. Additive Bayesian networks for antimicrobial resistance and potential risk factors in non-typhoidal Salmonella isolates from layer hens in Uganda. BMC Vet. Res. 15, 212 (2019).","journal-title":"BMC Vet. Res."},{"key":"289_CR19","doi-asserted-by":"publisher","unstructured":"Mure\u015fan, R., Zaharia, C. & Zaharie, D. Using additive bayesian networks and association rules in antimicrobial resistance analysis. in 2020 International Conference on e-Health and Bioengineering (EHB) 1\u20134 https:\/\/doi.org\/10.1109\/EHB50910.2020.9280255 (2020).","DOI":"10.1109\/EHB50910.2020.9280255"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"dlac068","DOI":"10.1093\/jacamr\/dlac068","volume":"4","author":"WJ Love","year":"2022","unstructured":"Love, W. J., Wang, C. A. & Lanzas, C. Identifying patient-level risk factors associated with non-\u03b2-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs. JAC-Antimicrob. Resist. 4, dlac068 (2022).","journal-title":"JAC-Antimicrob. Resist."},{"key":"289_CR21","doi-asserted-by":"crossref","unstructured":"Baraz, A., Chowers, M., Nevo, D. & Obolski, U. The time-varying association between previous antibiotic use and antibiotic resistance. Clin. Microbiol. Infect. 29, 390.e1\u2013390.e4 (2022).","DOI":"10.1016\/j.cmi.2022.10.021"},{"key":"289_CR22","unstructured":"Kratzer, G., Lewis, F. I., Comin, A., Pittavino, M. & Furrer, R. Additive Bayesian Network Modelling with the R Package abn. ArXiv Prepr. ArXiv191109006 (2019)."},{"key":"289_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-7622-10-4","volume":"10","author":"FI Lewis","year":"2013","unstructured":"Lewis, F. I. & Ward, M. P. Improving epidemiologic data analyses through multivariate regression modelling. Emerg. Themes Epidemiol. 10, 4 (2013).","journal-title":"Emerg. Themes Epidemiol."},{"key":"289_CR24","doi-asserted-by":"crossref","unstructured":"Kratzer, G., Lewis, F., Comin, A., Pittavino, M. & Furrer, R. Additive Bayesian Network Modeling with the R Package abn. J. Stat. Softw. 105, 1\u201341 (2023).","DOI":"10.18637\/jss.v105.i08"},{"key":"289_CR25","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2020)."},{"key":"289_CR26","first-page":"549","volume":"5","author":"M Koivisto","year":"2004","unstructured":"Koivisto, M. & Sood, K. Exact bayesian structure discovery in bayesian networks. J. Mach. Learn. Res. 5, 549\u2013573 (2004).","journal-title":"J. Mach. Learn. Res."},{"key":"289_CR27","first-page":"1","volume":"124","author":"M Plummer","year":"2003","unstructured":"Plummer, M. JAGS: a program for analysis of Bayesian graphical models using Gibbs sampling. Proc. 3rd Int. Workshop Distrib. Stat. Comput. 124, 1\u201310 (2003).","journal-title":"Proc. 3rd Int. Workshop Distrib. Stat. Comput."},{"key":"289_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.dib.2017.05.053","volume":"13","author":"M Pittavino","year":"2017","unstructured":"Pittavino, M. et al. Data on Leptospira interrogans sv Pomona infection in Meat Workers in New Zealand. Data Brief 13, 587\u2013596 (2017).","journal-title":"Data Brief"},{"key":"289_CR29","doi-asserted-by":"publisher","first-page":"e00346","DOI":"10.1128\/AAC.00346-20","volume":"64","author":"MD Zilberberg","year":"2020","unstructured":"Zilberberg, M. D., Nathanson, B. H., Sulham, K. & Shorr, A. F. Antimicrobial susceptibility and cross-resistance patterns among common complicated urinary tract infections in U.S. hospitals, 2013 to 2018. Antimicrob. Agents Chemother. 64, e00346\u201320 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"289_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.15252\/msb.20167028","volume":"13","author":"M Zampieri","year":"2017","unstructured":"Zampieri, M. et al. Metabolic constraints on the evolution of antibiotic resistance. Mol. Syst. Biol. 13, 917 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"289_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1128\/AAC.04819-14","volume":"59","author":"E Thulin","year":"2015","unstructured":"Thulin, E., Sundqvist, M. & Andersson, D. I. Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob. Agents Chemother. 59, 1718\u20131727 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"289_CR32","doi-asserted-by":"publisher","unstructured":"Baraz, A., Chowers, M., Nevo, D. & Obolski, U. Stable temporal relationships as a first step towards causal inference: an application to antibiotic resistance. 2022.01.31.22270156 Preprint at https:\/\/doi.org\/10.1101\/2022.01.31.22270156 (2022).","DOI":"10.1101\/2022.01.31.22270156"},{"key":"289_CR33","doi-asserted-by":"publisher","unstructured":"Cherny, S. S. & Obolski, U. R script for abn of antibiotic resistance. Zenodo https:\/\/doi.org\/10.5281\/zenodo.7670932 (2023).","DOI":"10.5281\/zenodo.7670932"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00289-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:18:40Z","timestamp":1683051520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00289-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00289-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"14 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}